HOME >> BIOLOGY >> NEWS
CRESIB coordinates an international consortium to fight malaria caused by Plasmodium vivax

The CRESIB has today presented the research programme on malaria by Plasmodium vivax, a parasite causing over 70 million yearly cases of malaria in the world. This new programme will be developed in coordination with the leading international centres and researchers on P.vivax. The aim of this study is to contribute to a better understanding of malaria by P. vivax and to support and accelerate the development of new control tools, with a special focus in vaccines. This fact will promote the creation and development of a research line on P. vivax in CRESIB under the direction of Dr. Hernando A. del Portillo, one of the few specialists in molecular biology and vaccine development against this parasite. The number of CRESIB labs will be increased, with an enlargement and restoration of current facilities to meet the needs of the centre.

Malaria is an infectious disease which can be caused by four species of the Plasmodium parasite: P. falciparum, P. vivax, P. malariae and P. ovale. P. falciparum and P. vivax are the most prevalent, the first being more virulent and responsible of most of the severe morbidity and mortality. Nevertheless, during the last years, there has been a growing interest in malaria by P. vivax, which, as well as causing millions of malaria cases every year, it also generates a high social and economic cost for endemic countries. It is estimated that about 2,600 million people live in risk zones for P. vivax: central and south-America, Asia, Middle East and occidental Pacific. Clinical and pathogen presentation of P. vivax is not well understood. Despite the traditional belief that clinical malaria caused by this species of the parasite is mild, there are evidences suggesting that it can cause severe clinical patterns and even death of patients.

The paradox is that even though malaria by P. vivax has large global disease burden, this is a poorly studied disease,
'"/>

Contact: Marc de Semir
mdesemir@clinic.ub.es
34-932-275-700
IDIBAPS - Institut d'Investigacions Biomdiques August Pi i Sunyer
17-Jul-2007


Page: 1 2

Related biology news :

1. NYU biologists identify gene that coordinates two cellular processes
2. American buffalo slaughter fueled by international trade
3. 2 MSU professors spearhead international water project
4. Nature surrenders flowery secrets to international team
5. Fibers are center stage at international conference
6. Creation of an international industrial chair in life cycle assessment
7. The Institute of Ecosystem Studies to host an international conference on ecology and urban design
8. No sign that ethnic groups genes cause diabetes, international research team says
9. Research director to be honored at international congress
10. First international conference on self-healing materials
11. Case Western researcher, international team call for better global warming forecasting

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/4/2020)... (PRWEB) , ... March 04, 2020 , ... ... founders and CEOs to apply to the MedTech IGNITE program’s 2020 IGNITE Cohort. ... and networking curriculum to attract and nurture the next generation of medtech founders ...
(Date:3/3/2020)... ... ... Amplify Surgical, Inc., today announces that the company reached the milestone of ... The landmark case was performed by Dr. Ali Najafi at Fresno Heart and Surgical ... changed the game for expandable interbodies. The ability to achieve an ALIF sized ...
(Date:3/2/2020)... PHILADELPHIA (PRWEB) , ... March 02, 2020 , ... Philadelphia ... Travis W. Bliss, Ph.D., J.D. has joined the firm as a Partner, and Stephany ... Bliss is an experienced patent attorney and will be a partner in the firm’s ...
Breaking Biology News(10 mins):
(Date:3/19/2020)... (PRWEB) , ... March 17, ... ... clinical supply and manufacturing collaboration agreement with pioneering gene circuit company Senti ... therapies for ovarian cancer and other solid tumor indications. The collaboration will ...
(Date:3/10/2020)... (PRWEB) , ... March 10, 2020 , ... Ortho Clinical ... through innovative laboratory solutions, announced its ORTHOTM Sera, ID-MTS, a suite of extended antigen ... transfusion, is cleared to run on ORTHO VISION® and ORTHO VISION® Max in the ...
(Date:3/4/2020)... ... 2020 , ... This month, Cognosante will make its annual appearance at the ... expanded and emerging offerings that align with the HIMSS annual theme, “Be the Change.” ... timely, and engaging. From Interoperability and HIE to Cloud Computing ...
(Date:2/28/2020)... ... February 26, 2020 , ... Designed ... high-speed camera with a dedicated controller, thus simplifying setup, streamlining integration, and optimizing ... is the first of Fastec Imaging’s new HS Series cameras to be released. ...
Breaking Biology Technology:
Cached News: